Nanoceutical’s Absorption Studies Don’t Pick Up Disease Claims In NAD Review
Executive Summary
National Advertising Division, on challenge by Council for Responsible Nutrition, recommends Nanoceutical Solutions discontinue efficacy and establishment claims for Nano Glutathione.
You may also be interested in...
OTC Nasal Antiseptic NanoBio Protect ‘Lethal’ In COVID-19 In Vitro Tests, Amazon Launch Soon
BlueWillow Biologics points to recent in vitro tests it conducted with Public Health England showing NanoBio Protect killed COVID-19 as additional support for using nasal antiseptics to help prevent infections from the novel coronavirus. The firm also will soon offer sales of NanoBio Protect on Amazon.
Jurors' Answers In FTC's Prevagen Complaint Might Burst A Memory Bubble For Health Claims
“No” answers in New York federal court on whether all but two of Prevagen claims were “materially misleading” could put a fork in the road of a long dispute between FTC and supplement product manufacturers and marketers.
MLM Group Not Buying FTC Executive’s Concerns About Its Income Disclosure Guidance
FTC Division of Marketing Practices assistant director concerned direct selling self-regulation group’s guidance “will encourage deceptive conduct and facilitate deceptive earnings claims.” DSA president says the concerns might reflect the thinking of agency’s staff more than the intent of the agency’s regulations.